Behavior Disorder Screening News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Behavior Disorder Screening. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Behavior Disorder Screening Today - Breaking & Trending Today

ANAVEX®2-73 (Blarcamesine) Shows Clinical Benefit in Long-Term 48-Week Phase 2 Extension Study in Patients with Parkinson's Disease Dementia

Published: March 30, 2023

Study successfully achieved both primary and secondary objectives ANAVEX®2-73 treatment resulted in improvements of all efficacy endpoints over 48 Weeks Anavex plans to proceed to... | March 30, 2023

Source: marketscreener.com

Related Topics:

United StatesChristopheru MisslingAndrewj BarwickiParkinson Progression Markers Initiative CohortCompany NasdaqResearch Business DevelopmentParkinson Progression Marker InitiativeMovement Disorder SocietyMichaelj Fox Foundation For Parkinson ResearchMichaelj Fox FoundationGlobenewswire IncAnavex Life Sciences CorpLife SciencesCentral Nervous SystemMovement Disorder Society Unified ParkinsonDisease Rating ScaleBehavior Disorder Screening QuestionnaireClinical Global ImpressionMontreal Cognitive AssessmentOpen Label ExtensionBehavior Disorder ScreeningSpecial AccessLife ScienceAnnual ReportFurther Information